Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine

Vaccine

Volumn 24, Issue 14, 2006, Pages 2530-2536

  Little, S F ^a   Ivins, B E ^a   Webster, W M ^a   Fellows, P F ^a,b   Pitt, M L M ^a,c   Norris, S L W ^a   Andrews, G P ^a,c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b A CSC Company   (United States)

^c UNIVERSITY OF WYOMING   (United States)

Author keywords

Anthrax; Immunity; rPA vaccine

Indexed keywords

ANTHRAX VACCINE; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIGEN; RECOMBINANT PROTECTIVE ANTIGEN VACCINE; TOXIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LOGISTIC REGRESSION ANALYSIS; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RABBIT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL; VACCINATION;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; RABBITS; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC;

EID: 33344473535     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.028     Document Type: Article

References (23)

1. L.L. Zwanziger J.S. Durch B.L. Strom The anthrax vaccine: is it safe? does it work? 2002 National Academies Press Washington, D.C.
2. S.H. Leppla The anthrax toxin complex J.E. Alouf JH. Freer Sourcebook of bacterial protein toxins 1991 Academic Press Inc. New York 277 302
3. J.L. Stanley, and H. Smith The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity J Gen Microbiol 31 1963 329 337
4. B.G. Mahlandt, F. Klein, R.E. Lincoln, B.W. Haines, W.I. Jones Jr., and R.H. Friedman Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin J Immunol 96 1966 727 733
5. B.E. Ivins, and S.L. Welkos Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis Infect Immun 54 1986 537 542
6. D.L. Fritz, N.K. Jaax, W.B. Lawrence, K.J. Davis, M.L.M. Pitt, and J.W. Ezzell Pathology of experimental inhalation anthrax in the rhesus monkey Lab Invest 73 5 1995 691 702
7. D. Vasconcelos, R. Barnewell, M. Babin, R. Hunt, J. Estep, and C. Nielsen Pathology of inhalation anthrax in cynomologus monkeys (Macaca fascicularis) Lab Invest 83 8 2003 1201 1209
8. G.M. Zaucha, M.L.M. Pitt, J. Estep, B.E. Ivins, and A.M. Freidlander The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation Arch Pathol Lab Med 122 11 1998 982 992
9. M.L.M. Pitt, S.F. Little, B.E. Ivins, P. Fellows, J. Barth, and J. Hewetson In vitro correlate of immunty in a rabbit model of inhalational anthrax Vaccine 19 2001 4768 4773
10. S.F. Little, B.E. Ivins, P.F. Fellows, M.L.M. Pitt, S.L.W. Norris, and G.P. Andrews Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine Vaccine 22 2004 422 430
11. H.M. Darlow, F.C. Belton, and D.W. Henderson The use of anthrax antigen to immunise man and monkey Lancet 2 1956 476 479
12. P.L. Worsham, and M.R. Sowers Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis Can J Microbiol 45 1999 1 8
13. J.W. Farchaus, W.J. Ribot, S. Jendrek, and S.F. Little Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis Appl Environ Microbiol 64 3 1998 982 991
14. S.H. Leppla Production and purification of anthrax toxin. S. Harshman Methods of enzymology vol. 165 1988 Academic Press, Inc. Orlando, FL 103 116
15. C.I. Bliss Provisionally normal distributions Statistics in biology vol. 1 1967 McGraw-Hill New York 152 185
16. F.C. Belton, and R.E. Strange Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production Br J Exp Pathol 35 1954 144 152
17. G.G. Wright, T.W. Green, and R.G. Knode Jr. Studies on immunity in anthrax V. Immunizing activity of alum-precipitated protective antigen J Immunol 73 1954 387 391
18. M. Puziss, and G.G. Wright Studies on immunity in anthrax X. gel-adsorbed protective antigen for immunization of man J Bacteriol 85 1962 230 236
19. B.E. Ivins, M.L.M. Pitt, P.F. Fellows, J.W. Farchaus, G.E. Benner, and D.M. Waag Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques Vaccine 16 11-12 1998 1141 1148
20. A.J. Phipps, C. Premanandan, R.E. Barnwell, and M.D. Lairmore Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines Microbiol Mol Biol Rev 68 4 2004 617 629
21. A.K. Boor An antigen prepared in vitro effective for immunization against anthrax I. preparation and evaluation of the crude protective antigen J Infect Dis 97 1955 194 202
22. H. Marcus, R. Danieli, E. Epstein, B. Velan, A. Shafferman, and S. Reuveny Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine Infect Immun 72 6 2004 3471 3477
23. P.R. Pittman, G. Kim-Ahn, D.Y. Pifat, K. Coonan, P. Gibbs, and S. Little Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans Vaccine 20 2002 1412 1420